Research Article
Nomogram to Predict Long-Term Overall Survival and Cancer-Specific Survival of Radiotherapy Patients with Nasopharyngeal Carcinoma
Table 3
Multivariate Cox regression analysis of overall survival and cancer-specific survival in nasopharyngeal carcinoma in the training cohort.
| Variables | Overall survival | Cancer-specific survival | HR | 95% CI | | HR | 95% CI | |
| Total | | | | | | | Age group (years) | | | | | | | <50 | Reference | | | Reference | | | 50-64 | 1.835 | 1.601-2.103 | <0.001 | 1.652 | 1.422-1.920 | <0.001 | ≥65 | 3.327 | 2.866-3.863 | <0.001 | 2.513 | 2.120-2.979 | <0.001 | Race | | | | | | | Black | Reference | | | Reference | | | White | 0.946 | 0.809-1.107 | 0.488 | 0.879 | 0.735-1.051 | 0.158 | Asian/Pacific islander | 0.737 | 0.620-0.875 | <0.001 | 0.781 | 0.644-0.948 | 0.012 | Indian/Alaska native | 1.411 | 0.978-2.034 | 0.065 | 1.399 | 0.923-2.120 | 0.114 | Marital status | | | | | | | Single | Reference | | | Reference | | | Married | 0.866 | 0.754-0.993 | 0.040 | 0.894 | 0.765-1.045 | 0.160 | Divorced | 1.282 | 1.065-1.544 | 0.009 | 1.279 | 1.033-1.584 | 0.024 | Windowed/separated | 1.406 | 1.143-1.729 | 0.001 | 1.376 | 1.079-1.753 | 0.009 | Histology | | | | | | | KSCC | Reference | | | Reference | | | DNKC | 0.715 | 0.619-0.824 | <0.001 | 0.718 | 0.611-0.844 | <0.001 | UNKC | 0.629 | 0.512-0.775 | <0.001 | 0.583 | 0.457-0.742 | <0.001 | Others | 0.920 | 0.804-1.054 | 0.229 | 0.870 | 0.745-1.017 | 0.081 | Grade | | | | | | | Well | Reference | | | Reference | | | Moderate | 0.911 | 0.635-1.306 | 0.612 | 0.915 | 0.599-1.398 | 0.682 | Poor | 0.794 | 0.565-1.116 | 0.184 | 0.794 | 0.532-1.185 | 0.259 | Undifferentiated | 0.759 | 0.529-1.088 | 0.133 | 0.735 | 0.481-1.123 | 0.154 | Unknown | 0.819 | 0.581-1.156 | 0.257 | 0.794 | 0.530-1.189 | 0.263 | Tumor size (cm) | | | | | | | <3 | Reference | | | Reference | | | 3-5 | 1.281 | 1.084-1.514 | 0.004 | 1.268 | 1.041-1.544 | 0.018 | >5 | 1.667 | 1.368-2.031 | <0.001 | 1.751 | 1.398-2.194 | <0.001 | Unknown | 1.482 | 1.270-1.728 | <0.001 | 1.523 | 1.270-1.827 | <0.001 | AJCC stage | | | | | | | I | Reference | | | Reference | | | II | 1.378 | 1.038-1.828 | 0.026 | 1.612 | 1.118-2.324 | 0.011 | III | 1.74 | 1.292-2.344 | <0.001 | 2.577 | 1.772-3.747 | <0.001 | IV | 1.632 | 1.165-2.287 | 0.004 | 2.508 | 1.668-3.771 | <0.001 | T stage | | | | | | | T1 | Reference | | | Reference | | | T2 | 1.045 | 0.891-1.225 | 0.589 | 1.097 | 0.912-1.319 | 0.327 | T3 | 1.218 | 1.013-1.465 | 0.036 | 1.146 | 0.931-1.411 | 0.198 | T4 | 1.611 | 1.281-2.025 | <0.001 | 1.528 | 1.193-1.957 | <0.001 | N stage | | | | | | | N0 | Reference | | | Reference | | | N1 | 0.899 | 0.770-1.051 | 0.182 | 0.918 | 0.767-1.099 | 0.351 | N2 | 0.925 | 0.785-1.091 | 0.356 | 0.892 | 0.740-1.076 | 0.232 | N3 | 1.368 | 1.089-1.717 | 0.007 | 1.34 | 1.047-1.716 | 0.020 | M stage | | | | | | | M0 | Reference | | | Reference | | | M1 | 2.926 | 2.437-3.512 | <0.001 | 3.278 | 2.701-3.978 | <0.001 | Chemotherapy | | | | | | | Yes | Reference | | | Reference | | | No/unknown | 1.488 | 1.274-1.738 | <0.001 | 1.593 | 1.328-1.911 | <0.001 |
|
|